Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion

Patients with multiple myeloma (MM) are typically of an advanced age and may have significant co-existing medical conditions. They have often had multiple lines of therapy and as such experience disease-related effects alongside associated treatment toxicities. Daratumumab is a monoclonal antibody a...

Full description

Bibliographic Details
Main Authors: Tracy King, Jacqueline Jagger, Jodie Wood, Carmel Woodrow, Alicia Snowden, Sally Haines, Christina Crosbie, Kristen Houdyk
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Asia-Pacific Journal of Oncology Nursing
Subjects:
Online Access:http://www.apjon.org/article.asp?issn=2347-5625;year=2018;volume=5;issue=3;spage=270;epage=284;aulast=King